Hosted on MSN

STRATA Highlights Excimer Laser as Effective Option for Atopic Dermatitis

HORSHAM, PA — STRATA Skin Sciences, Inc. (NASDAQ: SSKN) is marking Eczema Awareness Month by underscoring the growing body of clinical evidence supporting its XTRAC® Excimer Laser (308 nm) as a safe, ...
Seeking Alpha

Marking Eczema Awareness Month – Clinical Research Validates Strata Skin Sciences’ XTRAC® Excimer Laser as a Breakthrough Therapy for Localized Atopic Dermatitis

HORSHAM, Pa., Oct. 03, 2025 (GLOBE NEWSWIRE) -- In recognition of Eczema Awareness Month, STRATA Skin Sciences, Inc. (SSKN), a medical technology company dedicated to developing, commercializing, and ...
Reuters

Laser therapy may ease type of eczema

NEW YORK (Reuters Health) - Laser therapy that delivers a concentrated beam of ultraviolet light may help ease a hard-to-treat form of eczema, a small study suggests. The study, published in the ...
Nasdaq

STRATA Skin Sciences Highlights Study Validating Superior Efficacy of XTRAC® Excimer Laser Technology for Dermatologic Treatments

STRATA Skin Sciences announces a study validating its Excimer Laser technology's superiority in treating dermatological conditions compared to traditional UVB sources. STRATA Skin Sciences, Inc.
Seeking Alpha

STRATA Skin Sciences Announces Historic Expansion of CPT Codes for Reimbursement of 308nm Excimer Laser Treatments, Unlocking Access for Millions with Inflammatory and Auto ...

HORSHAM, Pa., May 19, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (SSKN) , a medical technology company dedicated to advancing dermatologic care through innovation, announces that the American ...